Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15 USD | 0.00% | +1.08% | +3.17% |
Jun. 05 | Trinity Capital Completes Liquidation of Core Scientific Shares | MT |
Jun. 05 | Trinity Capital to Provide $15 Million Funding to Restor3d | MT |
Strengths
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company is one of the best yield companies with high dividend expectations.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- For the last few months, analysts have been revising downwards their earnings forecast.
Ratings chart - Surperformance
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.17% | 742M | - | ||
-3.35% | 117B | A- | ||
+10.42% | 66.73B | - | B+ | |
+22.20% | 66.16B | C | ||
+13.72% | 44.04B | C+ | ||
+12.95% | 42.48B | A- | ||
+20.78% | 36.43B | A- | ||
+8.34% | 26.09B | B | ||
-3.58% | 22.44B | A- | ||
+1.26% | 18.67B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- TRIN Stock
- Ratings Trinity Capital Inc.